Dulaglutide, a long-acting GLP-1 receptor agonist, can suppress copeptin levels in individuals with euvolaemia, a secondary analysis of two clinical trials shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/dulaglutide-suppresses-copeptin-levels-euvolaemia-2026a10001ig?src=rss
Author :
Publish date : 2026-01-20 12:00:00
Copyright for syndicated content belongs to the linked Source.
